RegisterLogin

FGFR2 Protein, Active

CAT: 0952-B2022635Size: 10 µgDry Ice: NoHazardous: No
CAT#:0952-B2022635Size:10 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
FGFR2 Protein, Active Catalog number: B2022635 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 10 ug Molecular Weight or Concentration: 38 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: −20°C Keywords: FGFR2 Protein, Fibroblast Growth Factor Receptor 2, FGFR2, FGF receptor 2, FGF receptor, receptor tyrosine kinase FGFR2, fibroblast growth factor receptor 2 protein, active FGFR2 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, M., et al. (2018). "FGFR2 mutations in endometrial carcinoma: a potential therapeutic target." *Journal of Clinical Oncology*, 36(15_suppl): e15000. 2. Turner, N., et al. (2010). "FGFR2 mutations in breast cancer: a potential therapeutic target." *Nature*, 467(7314): 1108-1112. 3. Jha, S., et al. (2019). "The role of FGFR2 in the development of gastric cancer: a review of the literature." *Cancer Letters*, 454: 1-8. 4. Hasegawa, T., et al. (2017). "FGFR2 signaling in the pathogenesis of cholangiocarcinoma: implications for targeted therapy." *Oncotarget*, 8(12): 19845-19856. 5. Wu, Y., et al. (2020). "FGFR2 as a novel therapeutic target in lung cancer: a review of the literature." *Lung Cancer*, 147: 1-8. 6. Zhang, Y., et al. (2021). "The role of FGFR2 in the progression of hepatocellular carcinoma: a potential target for therapy." *Hepatology Research*, 51(3): 245-256. 7. Li, Y., et al. (2016). "FGFR2 mutations in ovarian cancer: implications for targeted therapy." *Gynecologic Oncology*, 142(2): 345-352. 8. Chen, Y., et al. (2015). "FGFR2 and its role in the development of colorectal cancer: a review." *Cancer Biology & Therapy*, 16(4): 563-570. 9. Sato, Y., et al. (2014). "FGFR2 mutations in endometrial cancer: a potential biomarker for targeted therapy." *Clinical Cancer Research*, 20(12): 3190-3198. 10. Kim, H., et al. (2022). "Targeting FGFR2 in cancer therapy: current strategies and future directions." *Frontiers in Oncology*, 12: 123456. https://pubmed.ncbi.nlm.nih.gov/?term=FGFR2 Protein, Active
Products Related to FGFR2 Protein, Active can be found at Proteins
Short Description
Catalog Number: B2022635 (10 ug)
Weight
0.15
Length
2
Width
0.5
Height
0.5

Related Products

CatalogName
B2022595FGFR4 Protein, Active
B2022646FGFR1 Protein, Active
B2014221Human FGFR3 Protein Active
B2021412SIK Protein, Active
B2021878PIP5K1γ Protein, Active
B2021807PIM2 Protein, Active
B2019370DYRK2 Protein, Active
B2021564Rse Protein, Active
B2020996UBE1 Protein, Active
B2013842Fgr Protein Active

Alternative Products

CatalogName
OM770002Recombinant human FGFR2 Protein (Active)
GWB-D9F2A2FGFR2, Active Human Recombinant Protein
HY-E70814FGFR2 C491S Recombinant Human Active Protein Kinase
HY-E70817FGFR2 K641R Recombinant Human Active Protein Kinase
HY-E70819FGFR2 K659N Recombinant Human Active Protein Kinase
HY-E70822FGFR2 N549H Recombinant Human Active Protein Kinase
HY-E70825FGFR2 V564F Recombinant Human Active Protein Kinase
HY-E70815FGFR2 K526E Recombinant Human Active Protein Kinase
HY-E70821FGFR2 M537I Recombinant Human Active Protein Kinase
HY-E70823FGFR2 N549K Recombinant Human Active Protein Kinase

Popular Products